• SM-102 for mRNA Delivery: Experimental Workflows and Trouble

  2026-05-15

  SM-102, a leading ionizable lipid, drives precise mRNA delivery in vaccine and therapeutic applications. This guide distills protocol parameters, advanced use-cases, and practical troubleshooting for SM-102-enabled lipid nanoparticles, referencing machine learning–aided optimization and real-world experimental data.

• Partial β-Secretase Inhibition Reduces Amyloid-β Without Syn

  2026-05-15

  Satir et al. (2020) show that moderate inhibition of β-secretase can decrease amyloid-β (Aβ) production by up to 50% without impairing synaptic transmission in rodent cortical neurons. This finding informs future Alzheimer’s disease (AD) therapeutic strategies, supporting cautious dose selection to avoid adverse effects on neural function.

• USP36-Snail1 Signaling Promotes Ribosome Biogenesis in Solid

  2026-05-14

  This study reveals how USP36 stabilizes nucleolar Snail1 during ribotoxic stress, promoting ribosome biogenesis and survival in solid tumor cells. The findings clarify resistance mechanisms to ribosome inhibitors like HHT and suggest new combinatorial therapy strategies.

• SB 431542 as a Precision ALK5 Inhibitor: Beyond TGF-β in Hum

  2026-05-14

  Explore SB 431542, a potent ALK5 inhibitor, in the context of human iPSC-derived sensory neuron models and TGF-β pathway modulation. This article uniquely connects selective kinase inhibition to advanced virology and neurobiology workflows.

• Clozapine N-oxide (CNO): Reliable Chemogenetic Solutions for

  2026-05-13

  This article offers practical, evidence-based guidance for researchers and lab technicians leveraging Clozapine N-oxide (CNO, SKU A3317) as a chemogenetic actuator in neuronal activity assays. It addresses common experimental pitfalls and demonstrates how CNO's selective DREADDs activation, purity, and workflow compatibility deliver reproducible, high-fidelity results.

• SM-102 in mRNA Delivery: Workflow Enhancements & Predictive

  2026-05-13

  SM-102 stands at the forefront of mRNA vaccine delivery, enabling reliable endosomal escape and high transfection efficiency. This article translates predictive, machine learning-driven advances and hands-on troubleshooting into actionable guidance for maximizing SM-102’s value in lipid nanoparticle workflows.

• Cy5-UTP in Advanced RNA Labeling: Workflows & Troubleshootin

  2026-05-12

  Cy5-UTP (Cyanine 5-uridine triphosphate) empowers researchers to synthesize highly fluorescent RNA probes for sensitive detection in applications like FISH, dual-color arrays, and mechanistic RNA tracking. This guide delivers stepwise workflows, application-driven tips, and troubleshooting strategies to maximize Cy5-UTP’s performance in modern molecular biology labs.

• Carfilzomib (PR-171): Advanced Workflows for Proteasome Inhi

  2026-05-12

  Carfilzomib (PR-171) empowers cancer researchers with robust, irreversible proteasome inhibition, enabling precise control over apoptosis and multi-modal cell death pathways. This article details optimized experimental protocols, troubleshooting insights, and emerging strategies—drawing on benchmark studies—to maximize reproducibility and translational impact in cancer research.

• Betaine Hydrochloride: Precision Tool for Metabolic and Prot

  2026-05-11

  Explore the scientific foundations and advanced applications of Betaine hydrochloride in metabolic enzyme and protease research. This article reveals unique protocol insights and comparative strategies for optimizing molecular biology workflows with high-purity reagents.

• Triptolide (PG490): Precision Inhibitor for Cancer Research

  2026-05-11

  Triptolide (PG490) stands out as a nanomolar-potency modulator of transcriptional and immune pathways, enabling reliable inhibition of cell proliferation and inflammatory responses in cancer and autoimmune models. This article bridges recent developmental and translational findings with actionable protocols and troubleshooting tips, making it indispensable for researchers seeking high-impact, reproducible data.

• Hematoxylin and Eosin Staining Kit: Technical Guide (K1142)

  2026-05-10

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) addresses the need for reproducible, high-contrast tissue morphology visualization in paraffin and frozen tissue section staining. It is intended for scientific research use only and should not be applied in diagnostic or clinical settings. Proper application supports reliable histopathological and cytological evaluation.

• Safe DNA Gel Stain: Sensitive, Safer DNA & RNA Gel Visualiza

  2026-05-09

  Safe DNA Gel Stain from APExBIO elevates nucleic acid detection by combining high sensitivity with blue-light compatibility, reducing mutagenic risk and DNA damage during gel imaging. Its flexible protocol integration and enhanced safety profile enable modern molecular biologists to streamline cloning and achieve reproducible results, surpassing traditional stains in both safety and performance.

• G-1 (CAS 881639-98-1): Selective GPR30 Agonist Evidence & Pr

  2026-05-09

  G-1 (CAS 881639-98-1) is a potent, selective GPR30 agonist that enables precise modulation of non-classical estrogen signaling. It is verifiably effective in GPR30-specific cardiovascular and oncology research, with nanomolar cellular potency and minimal off-target activity. This article synthesizes peer-reviewed evidence and APExBIO protocols for rigorous, reproducible research.

• S63845 MCL1 Inhibitor: Precision Targeting of Mitochondrial

  2026-05-08

  Explore the scientific underpinnings and advanced applications of S63845, a leading MCL1 inhibitor for mitochondrial apoptosis research. This article uncovers mechanistic insights, translational value, and unique comparative perspectives not found in existing resources.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Resp

  2026-05-07

  This study introduces a novel gastric cancer assembloid system integrating matched tumor organoids with patient-derived stromal cell subpopulations. The model captures microenvironment-driven drug resistance and cellular heterogeneity, enabling more predictive preclinical testing and insights for personalized therapy development.

16253 records 1/1084 page Next 12345 下5页 Last page